(19)

(11)

EP 2 569 284 A1

(12)

(43) Date of publication: 20.03.2013 Bulletin 2013/12 (21) Application number: 11721403.1 (22) Date of filing: 12.05.2011

(51) International Patent Classification (IPC):  C07D 213/82(2006.01) C07D 413/14(2006.01) A61P 35/00(2006.01) C07D 413/04(2006.01) A61K 31/4439(2006.01) (86) International application number: PCT/US2011/036242 (87) International publication number: WO 2011/143422 (17.11.2011 Gazette 2011/46)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (30) Priority: 12.05.2010 US 333854 P (71) Applicant: Vertex Pharmaceuticals Incorporated Cambridge, MA 02139 (US)	(72) Inventors: CHARRIER, Jean-Damien Abingdon Oxfordshire OX144RY (GB) DURRANT, Steven, John Abingdon Oxfordshire OX144RY (GB) KNEGTEL, Ronald, Marcellus Alphonsus Abingdon Oxfordshire OX144RY (GB) REAPER, Philip, Michael Abingdon Oxfordshire OX144RY (GB) (74) Representative: Coles, Andrea Birgit et al Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ London WC1R 4PJ (GB)